NCT05540925
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, Shanghai Municipality, China
Clinical trial condition
Hepatocellular Cancer
Explore clinical trials studying Hepatocellular Cancer. Study availability and eligibility vary by location and protocol.
57 public trials
15 recruiting studies
Hepatocellular Cancer trial results
NCT02141906
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +4 more
- Locations
-
- UT Southwestern Medical Center Dallas, Texas, United States
NCT02929082
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +4 more
- Locations
-
- Valérie Vilgrain Clichy, France
Completed
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
NCT04212286
- Conditions
- Diagnoses Disease, Digestive System Diseases, Digestive System Neoplasms, +6 more
- Locations
-
- Tianjin Third Central Hospital Tianjin, Tianjin Municipality, China
Completed
Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
NCT02947165
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +38 more
- Locations
-
- Sarah Cannon Research Institute SC Nashville, Tennessee, United States
- Huntsman Cancer Institute SC Salt Lake City, Utah, United States
- Novartis Investigative Site Salzburg, Austria
- Novartis Investigative Site Toronto, Ontario, Canada
NCT03474354
- Conditions
- Chemoembolization, Digestive System Diseases, Digestive System Neoplasms, +5 more
- Locations
-
- Evgenidion Hospital Athens, Attica, Greece
NCT03926039
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Lo-Hsu medical foundation Lotung Poh-Ai hospital Yilan, Taiwan
NCT02292173
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Hepatocellular Cancer, +5 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Completed
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
NCT01967823
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +36 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT04692454
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Cancer, +8 more
- Locations
-
- WanFangH Taipei, Taiwan